The KDIGO CKD 2024 Guideline Draft
It’s time for another NephJC draft! This time, the crew breaks down the 2024 KDIGO chronic kidney disease (CKD) guideline. This was the first update since 2012.
177Lu-edotreotide Improves PFS, OS Over Everolimus for SSTR-Positive GEP-NETs
MATTERHORN: Durvalumab Plus FLOT Improves EFS and pCR in Gastric, GEJ Cancers
Risk for Choledocholithiasis Higher in Older Adult Patients With Cholangiocarcinoma